CHALLENGES AND HOPES IN CRISPER CAS TECHNOLOGY IN FUTURE
PDF
HTML
PlumX
Scilit
Google Scholar
Semantic Scholar

Keywords

Genetic technology
Genome editing
Editing tool
CRISPR/Cas
Costeffective
Therapeutics

How to Cite

SRINIVASARAO, D., CHAUHAN, U., & CHARAN, L. S. (2021). CHALLENGES AND HOPES IN CRISPER CAS TECHNOLOGY IN FUTURE. SALT Journal of Scientific Research in Healthcare, 1(2), 05–12. https://doi.org/10.56735/saltjsrh.ms2101020512

Abstract

Genome editing is a flourishing tool that tends to be a boon for scientists to change an organism's DNA. With genome editing technology, scientists can add, remove or alter DNA, resulting in the inactivation of target genes, acquisition of novel genetic traits, and correction of pathogenic gene mutations. Different approaches were developed to edit the genome; one among them is CRISP-Cas which was recently developed. CRISPR associated proteins (CRISPR/Cas) are genome editing systems originated from prokaryotes that have allowed researchers to identify, photograph, alter, and annotate specific DNA and RNA sequences in a variety of living cells. Since using CRISPR/Cas is of low cost with high efficiency and good repeatability with a short cycle, it is used globally for genome editing. In the review, we analysed the utilisation of CRISPR/Cas as therapeutics to cure deadly diseases such as AIDS, Hepatitis B and human papillomavirus infection. Since CRISPR/Cas is cost-effective genome editing, the challenges to be faced in future due to usage of CRISPR/Cas and the areas where it can be utilised were discussed briefly in this review.

https://doi.org/10.56735/saltjsrh.ms2101020512
PDF
HTML
PlumX
Scilit
Google Scholar
Semantic Scholar
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2021 DARLA SRINIVASARAO, UGRESH CHAUHAN, LABISHETTY SAI CHARAN

Metrics

Metrics Loading ...